Recently added
This page was added on 04 June 2018.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
GlaxoSmithKline Australia
Administration route
Oral
Vaccine group
Rotavirus vaccines
Description:
Registered for use in infants, with an upper age limit for dose 2 of 24 weeks.
Live attenuated human rotavirus vaccine
Each 1.5 mL monodose pre-filled oral applicator or squeezable tube contains:
- ≥106.0 cell culture infectious dose 50% (CCID50) of the RIX4414 human rotavirus strain, type G1P[8]
- di-sodium adipate
- Dulbecco’s modified Eagle medium
- sterile water
For Product Information and Consumer Medicine Information about Rotarix visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Related diseases
Page history
Last updated
Last reviewed